Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
Clinical trial NCT03466450 · COMPLETED
Trial details
- NCT number
- NCT03466450
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2023-11-29
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.